Stock EMMLD OKYO PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart OKYO Pharma Limited

Equities

EMMLD

GG00BMFG5F62

Market Closed - Nasdaq
Other stock markets
 21:30:00 21/06/2024 BST 		5-day change 1st Jan Change
1.25 USD +0.81% Intraday chart for OKYO Pharma Limited -4.44% -29.38%
03-22 H.C. Wainwright Adjusts Price Target on OKYO Pharma to $7 From $6, Maintains Buy Rating MT
03-22 OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Multiple Signs and Symptoms of Dry Eye Disease including Ocular Pain Relief in its First-in-Human Phase 2 Trial of OK-101 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Biopharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
OKYO PHARMA LIMITED Stock OKYO Pharma Limited
 41.55M - - - - -
CSL LIMITED Stock CSL Limited
 93.91B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
 38.4B
BIOGEN INC. Stock Biogen Inc.
 32.61B
UCB Stock UCB
 28.2B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
 15.91B
  1. Stock Market
  2. Equities
  3. EMMLD Stock
  4. Charts OKYO Pharma Limited
  5. Sector Chart